Dose-dependent S-allyl cysteine ameliorates multiple sclerosis disease-related pathology by reducing oxidative stress and biomarkers of dysbiosis in experimental autoimmune encephalomyelitis

MARÍA DE MONTSERRAT FEIJÓO LÓPEZEDUARDO AGÜERA MORALESJAVIER CABALLERO VILLARRASOEVELIO FRANCISCO LUQUE CARABOTBEGOÑA MARIA ESCRIBANO DURÁN2026-01-292026-01-29201710.1016/j.ejphar.2017.09.0252-s2.0-85030031388https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/28452PharmacologyDose-dependent S-allyl cysteine ameliorates multiple sclerosis disease-related pathology by reducing oxidative stress and biomarkers of dysbiosis in experimental autoimmune encephalomyelitisresearch article